CIC and metabolic dysfunction-associated steatotic liver disease: In agreement with this idea, the activity of CTPI-2 and of a liver-targeted CIC knockout was recently studied in a well-established murine model of diet-induced Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), the diet-induced obesity (DIO) mouse model [16].